SB 412 establishes Maryland’s Community Forensic Aftercare Program within the Maryland Department of Health. The program monitors two groups: individuals committed to the health department due to being "not criminally responsible" (often called "not guilty by reason of insanity" cases), and people with mental illness or intellectual disability requiring community monitoring under specific legal circumstances. Key mechanisms include creating a community monitoring board to decide on conditional release and out-of-state travel, and requiring licensed social workers ("Program Monitors") to track compliance with court orders and make health recommendations. The bill amends Maryland’s Criminal Procedure and Health codes to implement this program, focusing on safety and structured oversight for these individuals.
SB 411 requires non-state hospitals in Maryland to establish clinical staffing committees with equal representation from management and frontline staff, including nurses, technicians, and other caregivers. These committees must develop evidence-based staffing plans considering patient acuity, staffing gaps, and daily patient needs, which hospitals must implement starting January 1, 2028. Hospitals must annually review these plans, publicly post staffing data on units, and submit annual reports to the Maryland Health Care Commission beginning in 2030. The bill directly affects hospital operations, staffing decisions, and transparency for frontline workers and patients.
SB 336 extends the deadline for the existing Task Force on Responsible Use of Natural Psychedelic Substances, established by 2024 law, to continue its work studying natural psychedelic substances like psilocybin and mescaline (excluding peyote). The task force, composed of state officials, experts, and community representatives, will study current laws, scientific data on benefits and risks, and barriers to access, then make recommendations for a state access program and legal changes. This extension allows the task force to finalize its report on creating equitable access to these substances and transitioning away from criminal penalties for nonviolent uses. The bill does not change current laws but prolongs the study period to inform future policy decisions.
SB 205 codifies federal mental health parity requirements into Maryland law, requiring health insurance carriers to comply with the Paul Wellstone and Pete Domenici Mental Health Parity Act. It mandates carriers to collect and report data on access to mental health and substance use disorder benefits, explain differences in care access, and undergo comparative analyses of nonquantitative treatment limitations. The Maryland Insurance Commissioner gains authority to review carrier reports and address noncompliance. This bill directly affects all health insurance carriers operating in Maryland, ensuring their coverage aligns with federal parity standards for mental health and substance use disorder benefits. It clarifies enforcement mechanisms without creating new benefit requirements.
HB 280 codifies Maryland’s health insurance requirements for mental health and substance use disorder coverage to align with federal parity laws. It requires health insurers to collect and report data on access to these services, explain differences in coverage rules, and comply with federal standards for equal treatment. The Maryland Insurance Commissioner will review insurer reports and address noncompliance. This bill directly affects health insurance companies and their policyholders seeking mental health or substance use disorder care.
SB 385 (The Vax Act) requires Maryland’s Secretary of Health to issue evidence-based recommendations for immunizations, screenings, and preventive services, aligning with guidance from major medical organizations like the CDC and U.S. Preventive Services Task Force. It expands pharmacists’ authority to administer vaccines (including those recommended by CDC or the Secretary) to patients aged 3+ after completing specific training and certification, while mandating health insurers to cover these services without cost-sharing. The bill also repeals outdated pertussis-related provisions and updates reporting requirements for pharmacists. This directly affects pharmacists, health insurers, and patients seeking preventive care, aiming to improve access to vaccinations and screenings.
HB 498 removes an existing exemption that allowed intermediate care facilities providing substance use disorder treatment to change bed capacity without a certificate of need. It specifically targets facilities offering "medically managed residential substance use disorder treatment services," requiring them to file 45 days' written notice with the health commission before operating or expanding. The commission must then review and approve these changes based on whether they align with the state health plan, improve service efficiency, and serve the public interest. This bill directly affects facilities providing residential substance use treatment by adding a review process for bed capacity changes or new operations, replacing the previous exemption.
HB 797 prohibits employers from discriminating against fire and rescue public safety employees who use medical cannabis, provided they have a valid written certification from a licensed healthcare provider under Maryland's medical cannabis program. The bill modifies existing law to clarify that an employer cannot take adverse employment actions (like termination or denial of promotion) solely due to medical cannabis use, as long as the employee meets the state's certification requirements. It updates definitions in Maryland law to ensure fire and rescue employees qualify for the same protections as other medical cannabis patients under the existing program. The law does not override workplace safety rules or require employers to accommodate cannabis use during work hours.
SB 866 requires chain restaurants with 20 or more locations in Maryland to display warning icons next to menu items exceeding 1,150mg sodium or 25mg added sugars per serving, starting January 1, 2028. The Maryland Department of Health must create these icons and guidelines by January 1, 2027, and run a public education campaign during 2027 to explain compliance. The bill directly affects large chain restaurants by mandating clear labeling of high-sodium and high-sugar menu items. It defines "high sodium" as 1,150mg per serving and "high added sugars" as 25mg per serving for labeling purposes.
HB 494 requires health insurance companies, nonprofit health service plans, and health maintenance organizations (HMOs) operating in Maryland to structure their reimbursements to primary care providers in a way that meets annual investment targets set by the state. Starting February 1, 2026, these entities must report their progress toward meeting these targets when filing new or updated premium rates with the Maryland Insurance Commissioner. The bill amends insurance code sections to mandate this reporting requirement as part of premium rate filings. It takes effect October 1, 2026, focusing on transparency and accountability for primary care funding.
